CD36 Glycosylation

Glycosylation refers to the process by which short-chain carbohydrates (oligosaccharides or glycans) covalently bind to specific amino acids on proteins. It is one of the important post-translational modifications of proteins in eukaryotes. Glycosylation modifications achieve various biological functions, such as cell recognition, signal transduction, and immune response, by affecting protein folding, localization, structure, transport, and biological activity.

CD36 (cluster of differentiation 36), also known as leukocyte differentiation antigen 36, is a highly glycosylated single-chain transmembrane glycoprotein of the multi-ligand B-type scavenger receptor family. It is widely distributed on the surface of various cells and is closely related to cell recognition, immune response, and various physiological and pathological processes. Studies have shown that the CD36 glycoprotein plays an important role in the pathogenesis of diseases such as atherosclerosis, hypertension, and diabetes. Therefore, CD36 glycosylation analysis is of great significance in the diagnosis of related diseases.

Biotech uses Thermo's latest Obitrap Fusion Lumos mass spectrometer to provide fast and accurateCD36glycosylation modification analysisone-stop technical package. You only need to tell us your experimental objectives and send us your samples. We will handle all subsequent matters of the project, including protein extraction, protease digestion, glycopeptide enrichment, peptide separation, mass spectrometry analysis, raw mass spectrometry data analysis, and bioinformatics analysis. Free consultations are welcome.

Submit Inquiry

Name *

Email Address *

Phone Number

Inquiry Project *

Project Description*

How to order?

Submit Inquiry